Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma

Clinical trial NCT07551349 · RECRUITING

Trial details

NCT number: NCT07551349
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Start date: 2026-02-02
Primary completion: 2027-04-14
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.